Exelixis reported third-quarter 2026 earnings and revenue above Wall Street estimates, according to an October 29 headline.
Non-GAAP earnings per share came in at US$0.94, US$0.04 above estimates. Revenue was US$658.7 million, beating estimates by US$10.19 million. The available information does not include the consensus figures or explain what drove the results.
Investor takeaway: Exelixis beat estimates for both earnings and revenue, but the information provided isn’t enough to assess the quarter’s underlying performance or its effect on the company’s outlook.
Exelixis Inc
EXEL.US
EXEL.US
Exelixis Inc
WealthAwesomeMarket cap
$16.40B
P/E
20.9x
52W high
$67.52
52W low
$36.00
1W change
+1.36%
Beta
0.47
Analyst Price Targets
Based on 18 analysts covering EXEL · as of Oct 20, 2026
Wall Street analysts forecast EXEL stock price to fall 16.1% over the next 12 months.
Consensus
Buy3.67 / 5.00
Avg. Target
C$55.53
-16.1% Upside
Previously C$54.87 on Oct 12, 2026
Current Price
C$66.20
Last close
Analyst Breakdown (18 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on EXEL's historical volatility
30-Day Vol
20.4%
Annualized
90-Day Vol
31.0%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$79.14
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$70.26 | C$65.48 – C$75.39 |
| 60 trading days | C$74.57 | C$67.50 – C$82.38 |
| 90 trading days | C$79.14 | C$70.05 – C$89.41 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
US$0.94 non-GAAP EPS, US$0.04 above estimates
Revenue reached US$658.7 million, US$10.19 million above estimates. The available figures don’t include consensus totals or comparable results from the prior year.
Bull case
Exelixis beat estimates on both reported measures: non-GAAP EPS by US$0.04 and revenue by US$10.19 million. Other supplied company metrics include a 35.3% profit margin and 44.4% return on equity, but they don’t show how those measures changed in Q3.
Bear case
The reported beats were modest, and the available information includes no year-over-year comparisons, guidance, or breakdown of revenue and costs. The headline alone doesn’t show whether the results changed Exelixis’s longer-term outlook.
What happened: Q3 earnings and revenue beat estimates
Exelixis reported third-quarter 2026 results above Wall Street estimates, according to the October 29 headline. Another supplied headline gives the key figures: non-GAAP EPS of US$0.94, US$0.04 above estimates, and revenue of US$658.7 million, US$10.19 million above estimates.
The available information doesn’t include the full earnings release, year-over-year comparisons, or details on what drove the results. Find the company’s listing on the EXEL.US stocks page.
What the numbers show: a small EPS beat and higher-than-estimated revenue
Non-GAAP EPS beat estimates by four cents, while revenue came in US$10.19 million above estimates. The consensus figures weren’t provided, so the size of each beat relative to the forecast can’t be calculated from this information alone.
Exelixis closed at US$66.20. The reported daily move was -0.12%, and volume was 9,719 shares, compared with a 20-day average of 2,182,868. These market figures don’t show how investors interpreted the earnings release. Other supplied metrics include trailing EPS of US$3.17 and a P/E of 20.8833; neither is identified as a Q3-specific result.
What to watch next: details behind the reported beats
The supplied headlines also mention a company financial-results announcement and corporate update, but don’t provide further details. The full results and company commentary could explain revenue, costs, and what drove the beats.
No guidance or forward-looking details are included, so the available information doesn’t show whether the quarter changes expectations for future performance. Visit the company’s EXEL.US stocks page.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
